Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-02-14

Clinical Trial Update: Efficacy of Vivomixx on Behaviour and Gut Function in Autism Spectrum Disorder [NA]

View source ↗

Summary

A completed clinical trial evaluating the efficacy of Vivomixx on behaviour and gut function in autism spectrum disorder; results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vivomixx (Probiotic formulation)

Snippet

Sponsor: University College, London | Conditions: Autism Spectrum Disorder | NA | Status: COMPLETED | Results posted: 2022-02-14